Last month, as one of its last major health policy actions, the Biden administration filed a proposed rule change by the ...

Australian researchers say they've come up with an anti-obesity treatment without the potential side effects of medicines ...

The rate of deaths from ischemic heart disease related to obesity nearly tripled in the U.S. over a two-decade span, according to new research. The rate for men more than ...

Junk food ad ban ‘will prevent an estimated 20,000 cases of childhood obesity’ - The Government confirmed the laying of ...

As the size of a person's belly grows, the memory center of their brain shrinks and beta amyloid and tau may appear — all of ...

With deaths from obesity-related heart disease reportedly increasing by 180% over the past 20 years, more research is being done to learn how GLP-1 medications such as Ozempic, Wegovy, Mounjaro and ...

Health-care companies were more or less flat as traders picked winners and losers in the race to sell obesity drugs. Recent data from an Amgen obesity-drug trial only reinforced investors' impressions ...

Research has shown that obstructive sleep apnea is an independent risk factor for depression, anxiety, and, more importantly, ...

Since 2018, Ozempic's net price has fallen from $531 to $290, or 45%. Since 2020, Rybelsus' net price has dropped from $376 to $296, or 21%. In contrast, Wegovy's net price has increased 21% since ...

Taking weight loss drugs like Wegovy and Zepbound can help people cut back on what they eat and also on what they drink – ...

Higher levels of visceral fat were related to increased amyloid, accounting for 77% of the effect of high body mass index ...